Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000009

PRESIDENT AND COO sold 22,500 shares at $474.65 ($10,679,686)

  • PRESIDENT AND COO acquired 22,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-09 Exercise or conversion : show line 1 in the form 10b5-1 +14,625 $117.76 $1,722,240 14,625 I
2026-02-09 Sale : show line 2 in the form 10b5-1 −14,625 $474.65 $6,941,796 0 I
2026-02-09 Exercise or conversion : show line 3 in the form 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
2026-02-09 Sale : show line 4 in the form 10b5-1 −7,875 $474.65 $3,737,890 0 I
Open-market sales · 22,500 sh · avg $474.65 · $10,679,686

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-09 Exercise or conversion : show line 5 in the form 10b5-1 Common Stock −14,625 24,000 I
2026-02-09 Exercise or conversion : show line 6 in the form 10b5-1 Common Stock −7,875 12,940 I
Loading xslF345X05/primarydocument.xml…